COVID-19 se asocia a un mayor riesgo de desarrollar el síndrome de Guillain-Barré, un trastorno autoinmune raro pero grave, según un nuevo estudio
Related Posts
Cleft Procedures Undervalued Relative to Craniofacial Procedures
TUESDAY, March 7, 2023 (HealthDay News) -- The current relative value unit (RVU)...
AHA News: How a Self-Care Expert Takes Care of Herself
WEDNESDAY, May 3, 2023 (American Heart Association News) -- Self-care means many...
Handgrip Strength, Neurocognitive Measures Linked in Older Adults
TUESDAY, June 28, 2022 (HealthDay News) -- Among men and women, handgrip...
Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
TUESDAY, Nov. 30, 2021 (HealthDay News) -- Regeneron Pharmaceuticals said...